AGP Executive Report
Last update: an hour agoMedtech Financing: Healthcare Holding Schweiz AG, a major Swiss medtech distributor with Liechtensteinische Landesbank among its lenders, has closed CHF 80 million in syndicated financing to fund further acquisitions and growth. Cardiovascular Drug Watch: NewAmsterdam Pharma and Menarini received a positive CHMP opinion for Ubeslo® (obicetrapib) and Evlarco® (obicetrapib plus ezetimibe) for primary hypercholesterolemia, with an EU marketing authorization decision expected in 2H26. Disability Benefits Rules: UK DWP guidance warns PIP claimants that holidays abroad longer than four weeks can trigger penalties or payment suspension unless they notify the DWP promptly and share travel details. Citizenship Test: The UK’s Life in the UK Test is required for many foreign applicants seeking British citizenship or settlement, with booking, cost, and exam structure set out by the government. Health & Wellness Context: A new piece on global literacy highlights how low adult reading rates—linked to conflict, poverty, and underfunded schooling—can undermine public health and long-term wellbeing.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.